Salicylidene acylhydrazide-mediated inhibition of type III secretion system-1 in Salmonella enterica serovar Typhimurium is associated with iron restriction and can be reversed by free iron

A. N. Layton, D. L. Hudson, A. Thompson, J. C. Hinton, J. M. Stevens, E. E. Galyov, M. P. Stevens

Research output: Contribution to journalArticlepeer-review

Abstract

Salmonella enterica serovar Typhimurium is an animal and zoonotic pathogen of worldwide importance. Intestinal colonization, induction of enteritis and systemic translocation by this bacterium requires type III protein secretion. Strategies that target this process have the potential to control infection, pathology and transmission. We defined the global transcriptional response of S. Typhimurium to INP0403, a member of a family of salicylidene acylhydrazides that inhibit type III secretion (T3S). INP0403 treatment was associated with reduced transcription of genes involved in T3S, but also increased transcription of genes associated with iron acquisition. We show that INP0403 restricts iron availability to Salmonella, and that inhibition of T3S system-1 by INP0403 is, at least in part, reversible by exogenous iron and independent of the iron response regulator Fur.
Original languageEnglish
Pages (from-to)114-122
Number of pages9
JournalFEMS Microbiology Letters
Volume302
Issue number2
DOIs
Publication statusPublished - Jan 2010

Keywords

  • Salmonella
  • type III secretion
  • inhibition
  • salicylidene acylhydrazide
  • iron

Fingerprint

Dive into the research topics of 'Salicylidene acylhydrazide-mediated inhibition of type III secretion system-1 in Salmonella enterica serovar Typhimurium is associated with iron restriction and can be reversed by free iron'. Together they form a unique fingerprint.

Cite this